Secondary malignancy after treatment of Hodgkin's disease: An evolving picture

C. N. Coleman

doi:10.1200/JCO.1986.4.6.821

Secondary malignancy after treatment of Hodgkin's disease: An evolving picture

C. N. Coleman

School of Medicine

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

The following questions regarding secondary ANLL, which were raised a number of years ago, are being answered. Is the type of chemotherapy used important? Does radiotherapy add to the risk of chemotherapy? Is the age of the patient at the time of treatment an important risk factor?

Original language	English (US)
Pages (from-to)	821-824
Number of pages	4
Journal	Journal of Clinical Oncology
Volume	4
Issue number	6
DOIs	https://doi.org/10.1200/JCO.1986.4.6.821
State	Published - Jan 1 1986

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.1986.4.6.821

Cite this

@article{7f7cc5be41334837b3fdfe3c3be3c356,

title = "Secondary malignancy after treatment of Hodgkin's disease: An evolving picture",

abstract = "The following questions regarding secondary ANLL, which were raised a number of years ago, are being answered. Is the type of chemotherapy used important? Does radiotherapy add to the risk of chemotherapy? Is the age of the patient at the time of treatment an important risk factor?",

author = "Coleman, {C. N.}",

year = "1986",

month = jan,

day = "1",

doi = "10.1200/JCO.1986.4.6.821",

language = "English (US)",

volume = "4",

pages = "821--824",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "6",

}

TY - JOUR

T1 - Secondary malignancy after treatment of Hodgkin's disease

T2 - An evolving picture

AU - Coleman, C. N.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - The following questions regarding secondary ANLL, which were raised a number of years ago, are being answered. Is the type of chemotherapy used important? Does radiotherapy add to the risk of chemotherapy? Is the age of the patient at the time of treatment an important risk factor?

AB - The following questions regarding secondary ANLL, which were raised a number of years ago, are being answered. Is the type of chemotherapy used important? Does radiotherapy add to the risk of chemotherapy? Is the age of the patient at the time of treatment an important risk factor?

UR - http://www.scopus.com/inward/record.url?scp=0022871688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022871688&partnerID=8YFLogxK

U2 - 10.1200/JCO.1986.4.6.821

DO - 10.1200/JCO.1986.4.6.821

M3 - Article

C2 - 3711957

AN - SCOPUS:0022871688

SN - 0732-183X

VL - 4

SP - 821

EP - 824

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 6

ER -

Secondary malignancy after treatment of Hodgkin's disease: An evolving picture

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this